BioMarin Pharmaceutical Inc.

BMRNNASDAQHealthcare● Active

$57.31

+$0.76(+1.34%)

Market Cap$11.1B

P/E Ratio—

52W High$66.28

52W Low$49.26

Avg Volume2.0M

Open$57.41

Beta0.24

Overview

BioMarin Pharmaceutical Inc. (BMRN) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BMRN · net income · updated Jun 10, 2026

Core profitability metrics

BMRN · net income · margin · TTM · CAGR

Net income was $348.9M for FY2025 (fiscal year ending 2025-12-31), down 18.3% year-over-year. Net profit margin was 10.8%. Based on available data, BioMarin Pharmaceutical Inc. has been profitable since at least 2020.

FY2025 Net Income$348.9M▼ -18.3% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

Net Profit Margin10.8%$348.9M ÷ $3.22B

YoY Change-18.3%—

5-Year CAGR-16.4%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 10, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2020

▸ FMP /income-statement · Annual · BMRN net income history · BMRN profit margin

Annual net income data

BMRN · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$348.9M▼ 18.3%10.8%$3.22B

FY2024$426.9M▲ +154.6%15.0%$2.85B

FY2023$167.6M▲ +18.4%6.9%$2.42B

FY2022$141.6M▲ +320.9%6.8%$2.10B

FY2021Loss−$64.1M▼ 107.5%-3.5%$1.85B

Net income vs peers (Healthcare)

BMRN vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

BioMarin Pharmaceutical Inc. (BMRN) reported net income of $348.9M for FY2025 (fiscal year ending 2025-12-31), down 18.3% year-over-year. The net profit margin was 10.8% — meaning the company kept $0.11 of every dollar of revenue as profit.

Based on available data, BioMarin Pharmaceutical Inc. has been profitable since at least 2020. Net income reached a peak of $854.0M in FY2020. Data available for 15 fiscal years.

BioMarin Pharmaceutical Inc.'s net profit margin was 10.8% for FY2025, based on the latest annual results.

Investors sometimes search for "BioMarin Pharmaceutical Inc. net worth" — the company's market capitalization is a separate figure from BMRN net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BMRN net income · 5 questions

BioMarin Pharmaceutical Inc. is profitable. The company reported net income of $348.9M for FY2025, a net profit margin of 10.8%. Net income was down 18.3% year-over-year. Based on available data, BioMarin Pharmaceutical Inc. has been profitable since at least 2020.

is BMRN profitabledoes BMRN make a profitBMRN profitabilityBMRN profitable company

▸ Source: FMP /income-statement · GAAP · BioMarin Pharmaceutical Inc. · BioMarin Pharmaceutical Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 10, 2026